Dean B, Hussain T, Hayes W, Scarr E, Kitsoulis S, Hill C, Opeskin K, Copolov DL (1999)
Changes in serotonin2A and GABAA receptors in schizophrenia: studies on the
human dorsolateral prefrontal cortex. J Neurochem 72: 1593–1599
Florijn WJ, Tarazi FI, Creese I (1997) Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. J Pharmacol Exp Ther 280:
561–569
Goldman-Rakic PS (1994) Working memory dysfunction in schizophrenia. J Neuropsychiat Clin Neurosci 6: 348–357
Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Neuropsychopharmacology 4: 245–256
Hatta Y, Hatta S, Saito T (1993) Effects of ceruletide on the dopamine receptoradenylate cyclase system in striatum and frontal cortex of rats chronically treated
with haloperidol. Psychopharmacology 110: 383–389
Hess EJ, Bracha HS, Kleinman JE, Creese I (1987) Dopamine receptors subtype imbalance schizophrenia. Life Sci 40: 1487–1497
Knable MB, Hyde TM, Murray AM, Herman MM, Kleinman JE (1996) A postmortem
study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric
controls, and normal controls. Biol Psychiatry 40: 1191–1199
Kurumaji A, Okubo Y (2000) D1 dopamine receptors, schizophrenia, and antipsychotic
medications. In: Lidow MS (ed) Neurotransmitter receptors in actions of antipsychotic medications. CRC Press LLC, Boca Raton, pp 65–78
Kurumaji A, Wakai T, Toru M (1997) Decreases in peripheral-type benzodiazepine
receptors in postmortem brains of chronic schizophrenics. J Neural Transm 104:
1361–1370
Lidow MS, Goldman-Rakic PS (1994) A common action of clozapine, haloperidol, and
remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.
Proc Natl Acad Sci USA 91: 4353–4356
Lidow MS, Elsworth JD, Goldman-Rakic PS (1997) Down-regulation of the D1 and D5
dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J Pharmacol Exp Ther 281: 597–603
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the
Folin phenol reagent. J Biol Chem 193: 265–275
Meadow-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ
(1996) Dopamine receptor mRNA expression in human striatum and neocortex.
Neuropharmacology 15: 17–29
Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ
(1997) Dopamine receptor transcript expression in striatum and prefrontal and
occipital cortex. Arch Gen Psychiatry 54: 1089–1095
Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue D, Terasaki O, Someya Y, Sassa T,
Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M (1997) Decreased prefrontal
dopamine D1 receptors in schizophrenia revealed by PET. Nature 385: 634–636
Seeman P (1995) Dopamine receptor: clinical correlate. In: Blooom FE, Kupfer DJ (eds)
Psychopharmacology: the fourth generation of progress. Raven Press, New York,
pp 295–302
Seeman P, Niznik HB (1990) Dopamine receptors and transporters in Parkinson's disease
and schizophrenia. FASEB J 4: 2737–2744
Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P,
Jellinger K, Tourtellotte WW (1987) Human brain D1 and D2 dopamine receptors
in schizophrenia, Alzheimer's, Parkinson's and Huntington's disease. Neuropsychopharmacology 1: 5–15
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL,
Gelernter JE, Rozmahel R, Yang Y, Israel Y, Seeman P, O'Dowd BF (1990) Human
dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347:
80–83
